Showing 99,581 - 99,600 results of 130,870 for search '(( a e decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 2.06s Refine Results
  1. 99581

    Speed-accuracy trade-offs for NCCS. by Radhakrishna Bettadapura (813776)

    Published 2015
    “…We applied NCCS with the expansion degree (L) varied between 5 to 20, on the synthesized EM dataset (blurring to 12A resolution) and using 30k samples in SO(3) space. …”
  2. 99582

    Regulation of <i>sup-35</i>and <i>pha-1</i> by UBC-18–ARI-1. by Kumaran Mani (262977)

    Published 2009
    “…Error bars (B and C) represent s.e.m. The means of the indicated groups were analyzed for significance using a two-tailed Student's t-test (*p<0.05 and **p<0.000). …”
  3. 99583

    Inhibition of RLC <i>Myl9</i> or its upstream kinases ROCK or MLCK results in defective palatal fusion. by Seungil Kim (717948)

    Published 2015
    “…(H, I) Immunostaining of E-cadherin in Y27632-treated explants cultured for 48 h illustrates maintenance of a multi-layered MES (I), whereas the control MES (H) has thinned by this stage. …”
  4. 99584

    Neuronal apoptosis in CA1 region of hippocampus induced by global cerebral ischemia. by Xiaojie Liu (290772)

    Published 2013
    “…<p>Detection of apoptosis in hippocampus CA1 pyramidal neurons was carried out using Tunel staing. The sham group showed a large number of neurons and almost no TUNEL-positive cells (5.1±1.2) (A). …”
  5. 99585

    Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  6. 99586

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  7. 99587

    Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  8. 99588

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  9. 99589

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  10. 99590

    Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  11. 99591

    Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  12. 99592

    DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  13. 99593

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  14. 99594

    DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  15. 99595

    Data_Sheet_1_Feeding Bacillus subtilis ATCC19659 to Broiler Chickens Enhances Growth Performance and Immune Function by Modulating Intestinal Morphology and Cecum Microbiota.docx by Taha M. Mohamed (12118524)

    Published 2022
    “…<p>This study investigated dietary supplementation with Bacillus subtilis (BS) ATCC19659 on growth performance, biochemical indices, intestinal morphology, and cecum microflora in broiler chicks. A total of 600 Arbor 1-day Acres broilers of either sex were allotted to 5 treatments: chicks were fed a corn- and soybean-based diet (CON); chicks were fed basal diet containing 500 mg ZnB/kg (ZnB); chicks were fed basal diet containing 1 × 10<sup>8</sup> CFU/g feed of BS-ATCC19659 (BS-1); chicks were fed basal diet containing 3 × 10<sup>8</sup> CFU/g feed of BS-ATCC19659 (BS-3); and chicks were fed basal diet containing 5 × 10<sup>8</sup> CFU/g feed of BS-ATCC19659 (BS-5). …”
  16. 99596

    Table 1_Global, regional, and national burden of myocarditis in children aged 0–14 years, 1990–2021: analysis for the global burden of disease study 2021.docx by Yi-Dong Zhang (20457863)

    Published 2024
    “…Over 30 years, the global incidence rate decreased from 8.27 (95% UI, 5.35–12.34) to 7.73 (95% UI, 4.99–11.55) per 100,000 population. …”
  17. 99597

    Table_1_An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotic... by Achraf El Mammery (17044986)

    Published 2023
    “…By WGS, the macrolide resistance genes detected were erm (59.8%), msrA (46%), and mphC (45.2%). The erm genes were more prevalent in MSSA (44/57, 77.2%) than in MRSA (38/80, 47.5%). …”
  18. 99598

    Anti-inflammatory and neuroprotective effects of catalase-transfected macrophages in PD murine models. by Matthew J. Haney (404721)

    Published 2013
    “…<p><b>A</b>: LPS-induced encephalitis in BALB/C mice were injected <i>i.v.…”
  19. 99599

    Ambivalent attachment for combinations of misleading and ambiguous exteroceptive cues. by David Cittern (5066369)

    Published 2018
    “…C: Proportions for a = b = 0.5 and c decreasing from 0.5 to 0. D: Proportions for a = b = 0.25 and c decreasing from 0.75 to 0.…”
  20. 99600

    Summary plots of P300 peak amplitude and latency means for averaged ERPs: larger and faster responses for most salient stimuli. by Marta Teixeira (514064)

    Published 2014
    “…<p>Top: A, B, C, E - mean peak amplitudes for A. Color/Luminance (exp I); B. …”